Effects of a Collagen Supplement on Quality of Life, Appetite and Glycaemic Control

Exclusion Criteria

• •1. Participant has a history or presence of uncontrolled and/or clinically important pulmonary, cardiac, hepatic, renal, endocrine (including type 1 and 2 diabetes), hematologic, immunologic, neurologic (e.g., Alzheimer's or Parkinson's diseases), psychiatric (including unstable depression and/or anxiety disorders) or biliary disorders.
• •2. Participant has a clinically important gastrointestinal (GI) condition that would potentially interfere with the evaluation of the study product \[e.g., inflammatory bowel disease, irritable bowel syndrome, chronic constipation, severe constipation (in the opinion of the investigator), history of frequent diarrhoea, history of surgery for weight loss, gastroparesis, systemic disease that might affect gut motility according to the investigator, medication managed reflux and/or clinically important lactose intolerance.
• •3. Participant has a history of chronic insomnia (defined as insomnia at least 3 d/week over the past month), a diagnosed sleep disorder (e.g., OSA), or a chronic medical condition that may impact energy/fatigue levels, in the judgment of the investigator.
• •4. Participant is a female who is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential and is unwilling to commit to the use of a medically approved form of contraception throughout the study period. The method of contraception must be recorded.
• •5. Participant has a known allergy, intolerance, or sensitivity to any of the ingredients in the study product, including bovine animal products.
• •6. Participant has a history or presence of cancer in the prior two years, except for non-melanoma skin cancer.
• •7. Participant has experienced any major trauma or any other surgical event within three months of Virtual Visit 1.
• •8. Participant has unstable use of a medication or supplement that the investigator considers may affect the outcomes of the trial.
• •9. Participant is currently in another biomedical research study or has been in the 30 days before screening.
• •10. Participant is an employee of, or has a financial interest in Darling Ingredients Inc.
• •11. The individual has a condition the investigator believes would interfere with his ability to provide informed consent and to comply with the study protocol, which might confound the interpretation of the study results, or put the participant at undue risk.
• •12. Participant is a vegan or vegetarian or excludes bovine products for cultural or religious reasons.